| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.3B | $2.4B | $2.7B | $3.1B | $3.1B | $0.8B | $0.8B | — |
| Cost of Revenue | $1.1B | $1.1B | $1.3B | $1.5B | $1.4B | $1.4B | $1.5B | $1.4B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.8B | $0.8B | $0.8B | $0.9B | $0.9B | $0.7B | $0.7B | $0.7B |
| Operating Income | $0.1B | $-0.0B | $0.4B | $0.1B | $0.5B | $0.1B | $0.0B | $0.1B |
| Net Income | $0.1B | $-0.2B | $0.2B | $0.0B | $0.3B | $0.1B | $-0.0B | $0.1B |
| EPS (Basic) | $2.01 | $-5.10 | $4.92 | $0.18 | $5.92 | $2.15 | $-0.15 | $1.27 |
| EPS (Diluted) | $1.66 | $-5.10 | $4.90 | $0.17 | $5.77 | $2.09 | $-0.15 | $1.24 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.9B | $4.4B | $5.0B | $5.6B | $5.7B | $5.2B | $5.6B | $5.3B |
| Current Assets | $1.3B | $1.7B | $1.6B | $1.9B | $2.0B | $1.9B | $2.3B | $2.0B |
| Cash & Equivalents | $0.5B | $0.8B | $0.6B | — | — | — | — | $0.6B |
| Total Liabilities | $2.9B | $3.4B | $3.7B | $4.5B | $4.6B | $4.3B | $4.6B | $4.6B |
| Current Liabilities | $0.8B | $0.7B | $0.9B | $1.2B | $1.1B | $0.9B | $0.8B | $0.8B |
| Stockholders' Equity | $1.0B | $0.9B | $1.0B | $0.8B | $0.9B | $0.6B | $0.7B | $0.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.4B | $0.2B | $0.2B | $0.1B | $0.7B | $0.5B | — |
| Investing Cash Flow | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.1B | — |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.6B | $-0.1B | $-0.5B | $-0.1B | $-0.1B | $-0.6B | $-0.1B | — |